Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
PL 02 - Presidential Symposium including Top 3 Abstracts and James Cox Lectureship Award Presentation
- 08:15 - 09:45
- 10/17/2017
- Location: Plenary Hall (Exhibit Hall D)
- Type: Plenary Session
- Track: Early Stage NSCLC
- Moderators:Hisao Asamura, Keunchil Park
-
+
PL 02.02 - Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC
08:20 - 08:30 | Presenter: R. Hui | Author(s): M. Özgüroğlu, D. Daniel, D.V. Baz, S. Murakami, T. Yokoi, A. Chiappori, K.H. Lee, M. De Wit, B. Chul Cho, J.E. Gray, A. Rydén, L. Viviers, L. Poole, P.A. Dennis, S.J. Antonia
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 09:00 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P2.01-065 - Clinico-Radiological and Pathological Evaluation of Lung Adenocarcinoma with Infiltration on the Computed Tomography of the Chest
09:00 - 09:00 | Presenter: Asuka Okada | Author(s): S. Choh, T. Nakai, C. Ohbayashi, Y. Kurono, M. Ueda, K. Katayama, N. Koguchi, S. Murakami, H. Takenaka
- Abstract
Loading...
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-036 - Comparing the Efficacy/Toxicity of Osimertinib and First Line EGFR-TKI by Individual Patient Analysis
09:30 - 09:30 | Presenter: Shoko Narita | Author(s): Yasushi Goto, J. Sato, R. Morita, S. Murakami, Shintaro Kanda, Hidehito Horinouchi, Y. Fujiwara, N. Yamamoto, Yuichiro Ohe
- Abstract
Loading... -
+
P2.03-048 - Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib
09:30 - 09:30 | Presenter: Yuki Shinno | Author(s): Yasushi Goto, J. Sato, R. Morita, Y. Matsumoto, S. Murakami, Shintaro Kanda, Hidehito Horinouchi, Y. Fujiwara, N. Yamamoto, Yuichiro Ohe
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-011 - Long Follow up from Phase I Study of Nivolumab and Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Shintaro Kanda | Author(s): Yuichiro Ohe, Y. Matsumoto, S. Murakami, Yasushi Goto, Hidehito Horinouchi, Y. Fujiwara, H. Nokihara, N. Yamamoto, T. Yamamoto, T. Tamura
- Abstract
Loading...